Closing in on an optimal EUS-guided liver biopsy technique… but when should we use it?

Despite the growth of noninvasive assessments of the liver by the use of risk scores and transient elastography, liver biopsy remains a cornerstone in the evaluation and management of hepatic disease. Moreover, histologic sampling of the liver is poised to become even more critical moving forward in light of the alarming increase in the incidence of nonalcoholic fatty liver disease, where the differentiation of steatosis from steatohepatitis and...